Prodominance and Incidence of Pseudomonas Bacteria in Urinary Samples from Women with Chronic Urinary Tract Infections
Dominasi dan Insidensi Bakteri Pseudomonas pada Sampel Urin dari Wanita dengan Infeksi Saluran Kemih Kronis
-
(1) * Hanan Kareem Saleem
Department of nursing, Technical institute of Babylon,Alfurat alAwast Technical university (ATU)
Iraq
(*) Corresponding Author
Abstract
Background; Chronic urinary tract infections in women are often associated with Pseudomonas aeruginosa, a significant pathogen causing recurrent and persistent infections. Aims of the study; To assess the predominance and incidence of Pseudomonas aeruginosa in urinary samples from women with chronic urinary tract infections. Methodology; A cross-sectional study at Al-Habbobi Teaching Hospital (10/11/2023–11/11/2024) examined bacterial infections in urinary samples from 1000 UTI patients (aged 35–45). Samples were cultured and analyzed for bacterial identification and antimicrobial susceptibility. Sociodemographic and clinical data were collected using questionnaires, ensuring ethical compliance and participant confidentiality. Result; The study included 1000 participants, with 60% in the 35–40 age group, 75% married, 60% having a college education, and 50% employed. Forty percent had a UTI history of 1–3 years. The most common bacteria in urine samples were Escherichia coli (45%), followed by Pseudomonas aeruginosa (22%), Klebsiella pneumoniae (15%), and Enterococcus faecalis (7%). Infection rates of Pseudomonas aeruginosa were highest in patients with UTIs lasting 4–7 years (40.91%), followed by those with >7 years (36.36%) and 1–3 years (22.73%). The 35–40 age group had the highest prevalence of Pseudomonas (59.09%). Conclusions; The study concludes that Escherichia coli and Pseudomonas aeruginosa are the most prevalent bacteria in UTIs, with Pseudomonas being more common in patients aged 35–40 and with longer infection durations.
Highlights:
- Chronic UTIs often involve Pseudomonas aeruginosa, causing persistent infections.
- Escherichia coli (45%) and Pseudomonas aeruginosa (22%) dominate UTI pathogens.
- Pseudomonas prevalence increases with age (35–40) and longer infection durations.
Keywords: Escherichia coli, Pseudomonas aeruginosa, Urinary tract infections (UTIs), Chronic infections, Biofilms, Antibiotic resistance
References
D. A. Ahmed, "Prevalence of Proteus spp. in some hospitals in Baghdad city," Iraqi Journal of Science, vol. 56, pp. 665–672, 2015.
T. Bjarnsholt, "The role of bacterial biofilms in chronic infections," APMIS Supplementum, vol. 121, no. 136, pp. 1–58, 2013.
D. J. Farrell, I. Morrissey, D. De Rubeis, M. Robbins, and D. Felmingham, "A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection," Journal of Infection, vol. 46, no. 2, pp. 94–100, 2020.
A. L. Flores-Mireles, J. N. Walker, M. Caparon, and S. J. Hultgren, "Urinary tract infections: Epidemiology, mechanisms of infection and treatment options," Nature Reviews Microbiology, vol. 13, no. 5, pp. 269–284, 2015.
B. Foxman, "Urinary tract infection syndromes: Occurrence, recurrence, bacteriology, risk factors, and disease burden," Infectious Disease Clinics of North America, vol. 28, no. 1, pp. 1–13, 2014.
A. U. Habibu, "Prevalence of Proteus mirabilis and Pseudomonas aeruginosa among female patients with suspected urinary tract infections attending Muhammad Abdullahi Wase specialist hospital, Kano, Nigeria," The International Journal of Engineering and Science (IJES), vol. 3, no. 3, pp. 231–236, 2014.
I. K. Flaifel, A. A. Ali, R. Q. Taha, M. A. Issa, O. A. Mohsein, and H. A. Khalid, "Frequency and sensitivity of Proteus spp., Pseudomonas spp., and Staphylococcus spp. in urine cultures," Central Asian Journal of Medical and Natural Science, vol. 4, no. 6, pp. 889–900, 2023.
S. S. Kanj and Z. A. Kanafani, "Current concepts in antimicrobial therapy against resistant Gram-negative organisms: Extended-spectrum β-lactamase–producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa," Mayo Clinic Proceedings, vol. 86, no. 3, pp. 250–259, 2011.
J. A. Khan, et al., "Prevalence and resistance pattern," Pakistan Journal of Pharmaceutical Sciences, vol. 21, no. 3, 2008.
T. Khawcharoenporn, S. Vasoo, and K. Singh, "Urinary tract infections due to multidrug-resistant Enterobacteriaceae: Prevalence and risk factors in a Chicago emergency department," Emergency Medicine International, vol. 2013, Article ID 258517, 2013.
M. Koeijers, et al., "Urinary tract infection in male general practice patients: Uropathogens and antibiotic susceptibility," Urology, vol. 76, no. 2, pp. 336–340, 2010.
P. M. Lepper, E. Grusa, H. Reichl, D. Häussinger, and H. Hoffmann, "Consumption of antibiotics and development of resistance in Gram-negative pathogens in an intensive care unit," Antimicrobial Resistance and Infection Control, vol. 1, no. 1, pp. 1–7, 2018.
E. Maglian, et al., "Gender and age-dependent etiology of community-acquired urinary tract infections," The Scientific World Journal, 2012.
M. M. Mihai, A. L. Preda, and L. G. Popa, "Antibiotic resistance in chronic urinary tract infections: Challenges and solutions," Journal of Global Antimicrobial Resistance, vol. 31, pp. 113–118, 2022.
R. Mittal, et al., "Urinary tract infections caused by Pseudomonas aeruginosa: A minireview," Journal of Infection and Public Health, vol. 2, no. 3, pp. 101–111, 2009.
M. A. Mohammed, et al., "Prevalence and antimicrobial resistance pattern of bacterial strains isolated from patients with urinary tract infection in Messalata Central Hospital, Libya," Asian Pacific Journal of Tropical Medicine, vol. 9, no. 8, pp. 771–776, 2016.
H. J. Morrill, A. R. Caffrey, E. Noh, and K. L. LaPlante, "Antimicrobial resistance of Pseudomonas aeruginosa in diabetic foot infections: A systematic review and meta-analysis," International Journal of Antimicrobial Agents, vol. 44, no. 5, pp. 429–435, 2019.
P. Pardeshi, "Prevalence of urinary tract infections and current scenario of antibiotic susceptibility pattern of bacteria causing UTI," Indian Journal of Microbiology Research, vol. 5, no. 3, pp. 334–338, 2018.
B. Rada, K. Lekstrom, and M. Carlson, "Quorum sensing in Pseudomonas aeruginosa: Interactions between host and pathogen," Journal of Microbiological Methods, vol. 82, no. 3, pp. 300–311, 2020.
R. Ramphal and P. G. Ambrose, "Extended-spectrum β-lactamases and clinical outcomes: Current data," Clinical Microbiology and Infection, vol. 25, no. 8, pp. 899–904, 2019.
W. D. Seifu and A. D. Gebissa, "Prevalence and antibiotic susceptibility of uropathogens from cases of urinary tract infections in Shashemene Referral Hospital, Ethiopia," MBC Infectious Diseases, vol. 18, pp. 1–9, 2018.
K. Stamatiou, I. Koutouzis, and M. Tsiatas, "Chronic urinary tract infections: Current diagnostic and therapeutic approaches," Medical Science Monitor, vol. 27, Article e933832, 2021.
World Health Organization (WHO), "Antimicrobial resistance," 2020. [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance.
